Provita Centrum Medyczne sp. z o.o.

General medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-07-12
Share capital
10,000.00 PLN
Activity description

Provita Centrum Medyczne is a clinical research center with facilities in Piotrków Trybunalski, Tomaszów Mazowiecki, and Warsaw. It currently conducts studies on various conditions, including cardiometabolic issues, non-metastatic and metastatic head and neck cancers, prostate cancer, and angina. The center is actively recruiting patients for these clinical trials.

Registered address
ul. Bagatela 10/28, 00-585 Warszawa, Poland
Phone
Social media

Offer

  • Clinical trials
  • Cardiodiabetology study
  • Head and neck cancer study
  • Prostate cancer study
  • Angina study

Websites

  • provitacm.plStrona główna - Provita Centrum Medyczne
    WordPress 3.7ElementorYoast SEOCloudflare

Authorized Representatives

Radosław Lipiński age 50 – Management Board Member
Michał Masłowski age 44 – Management Board Member

Manner of representation

For making declarations of will on behalf of the company with respect to non-property rights and obligations and property rights and obligations up to the equivalent of PLN 50,000.00, the action of one member of the management board is required; whereas, in the case of making declarations of will on behalf of the company with respect to property rights and obligations which, in a single transaction or as a result of aggregating recurring performances, exceed PLN 50,000.00, the joint action of two members of the management board is required.

Ownership

OwnerSharesShare valueStake
50$1,350.6250%
50$1,350.6250%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-12-07.

  • mBank
    67 1140 2004 0000 3902 7636 5490
  • mBank
    60 1140 2004 0000 3112 0584 7944

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $11,531.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$202
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$9,231
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
PPD Poland sp. z o.o.
Pratia S.A.
Kapadi sp. z o.o.
Clinchoice sp. z o.o.
Bioresearch Group sp. z o.o.
Oncotransfer sp. z o.o.
CTI Clinical Trial and Consulting Services Poland sp. z o.o.
Clinical Research Group sp. z o.o.
ETG Network sp. z o.o.
Biomedical Centers sp. z o.o.

FAQ

Last updated: 2026-04-18